Drawing for BREEZULA

USPTO serial 99245158

BREEZULA

Reviewed by CopyMark Law Group

Reg. 8375526Status 700Registered
Filing date
Status date
Registration date
Aug 4, 2026
Examiner
PARKER, JUSTINE D
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BREEZULA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Pickerill

John Pickerill Fredrikson & Byron, P.A.60 South 6th Street, Suite 1500Minneapolis, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
003Non-medicated cosmetics for the care and treatment of the skin; cosmetics; non-medicated cosmetics for the care and treatment of the scalp; hair lotions; non-medicated skin care preparations for the care and treatment of the skin and/or of the scalp; non-medicated skin care preparations for the person aimed at the preservation of the beauty and health of the body; skin cleansers; scalp cleansers; detergent soapACTIVE—
005Dermatological pharmaceutical preparations for acne, alopecia, warts; pharmaceutical preparations for the care and treatment of the skin; pharmaceutical preparations for the care and treatment of the scalp; pharmaceutical preparations for the treatment of alopecia; medicated lotions for the skin; medicated lotions for the scalp; medicinal creams for the care and treatment of the skin; pharmaceutical preparations for wounds; pharmaceutical preparations having tissue regenerative properties; disinfectants; pharmaceutical preparations having bactericidal action; food supplements; vitamin supplements; nutritional supplements; dietary supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 4, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 4, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 16, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 16, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 10, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 21, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 19, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 19, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 19, 2026ALIEASSIGNED TO LIE—
May 14, 2026ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 17, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 17, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Nov 17, 2025CNSLSUSPENSION LETTER WRITTEN—
Nov 10, 2025DOCKASSIGNED TO EXAMINER—
Oct 29, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 20, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 20, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance